Shell Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1M Sell
13,329
-48,447
-78% -$3.32M 0.1% 232
2025
Q2
$4.26M Buy
61,776
+15,491
+33% +$1.02M 0.15% 140
2025
Q1
$3.14M Buy
46,285
+16,289
+54% +$975K 0.15% 138
2024
Q4
$1.35M Sell
29,996
-19,001
-39% -$1.07M 0.06% 262
2024
Q3
$3.08M Buy
+48,997
New +$2.86M 0.14% 146
2024
Q1
$4.12M Buy
69,834
+5,053
+8% +$386K 0.19% 93
2023
Q4
$5.12M Sell
64,781
-13,409
-17% -$954K 0.24% 82
2023
Q3
$5.46M Sell
78,190
-2,179
-3% -$154K 0.23% 85
2023
Q2
$5.56M Buy
80,369
+14,181
+21% +$1.01M 0.22% 88
2023
Q1
$4.92M Buy
66,188
+1,012
+2% +$84.9K 0.2% 102
2022
Q4
$6.07M Sell
65,176
-2,665
-4% -$257K 0.27% 75
2022
Q3
$6.47M Sell
67,841
-3,106
-4% -$307K 0.25% 78
2022
Q2
$6.57M Sell
70,947
-18,676
-21% -$1.82M 0.19% 112
2022
Q1
$9.07M Sell
89,623
-3,329
-4% -$350K 0.21% 94
2021
Q4
$9.59M Buy
92,952
+12,901
+16% +$1.19M 0.2% 106
2021
Q3
$6.79M Buy
80,051
+5,273
+7% +$442K 0.15% 148
2021
Q2
$6.24M Sell
74,778
-5,074
-6% -$416K 0.12% 188
2021
Q1
$6.01M Sell
79,852
-28,281
-26% -$2.06M 0.12% 197
2020
Q4
$7.38M Buy
108,133
+23,950
+28% +$1.56M 0.15% 157
2020
Q3
$4.92M Buy
84,183
+4,336
+5% +$270K 0.11% 189
2020
Q2
$5.19M Sell
79,847
-19,598
-20% -$1.23M 0.13% 180
2020
Q1
$5.9M Sell
99,445
-11,660
-10% -$778K 0.16% 158
2019
Q4
$8.25M Sell
111,105
-2,089
-2% -$147K 0.18% 149
2019
Q3
$7.14M Sell
113,194
-881
-0.8% -$52.2K 0.16% 159
2019
Q2
$6.22M Sell
114,075
-4,114
-3% -$222K 0.14% 192
2019
Q1
$6.37M Hold
118,189
0.14% 187
2018
Q4
$7.74M Buy
118,189
+38,172
+48% +$2.85M 0.19% 141
2018
Q3
$6.3M Sell
80,017
-20,318
-20% -$1.45M 0.12% 199
2018
Q2
$6.46M Buy
100,335
+3,832
+4% +$253K 0.13% 193
2018
Q1
$6M Hold
96,503
0.12% 212
2017
Q4
$7M Buy
96,503
+16,927
+21% +$1.23M 0.14% 193
2017
Q3
$6.47M Sell
79,576
-18,357
-19% -$1.45M 0.14% 184
2017
Q2
$7.88M Sell
97,933
-1,285
-1% -$101K 0.17% 168
2017
Q1
$7.79M Sell
99,218
-3,047
-3% -$243K 0.17% 166
2016
Q4
$8.07M Sell
102,265
-26,251
-20% -$2.12M 0.19% 146
2016
Q3
$11.4M Sell
128,516
-12,978
-9% -$1.23M 0.24% 117
2016
Q2
$13.5M Buy
141,494
+11,530
+9% +$1.15M 0.31% 85
2016
Q1
$13.5M Sell
129,964
-2,007
-2% -$195K 0.32% 80
2015
Q4
$12.9M Sell
131,971
-111,640
-46% -$10.9M 0.3% 79
2015
Q3
$19.4M Buy
243,611
+59,252
+32% +$6.23M 0.31% 65
2015
Q2
$19.3M Sell
184,359
-20,599
-10% -$2.1M 0.39% 54
2015
Q1
$21.2M Sell
204,958
-61,024
-23% -$6.17M 0.37% 56
2014
Q4
$25.6M Buy
265,982
+22,371
+9% +$1.97M 0.41% 53
2014
Q3
$19.4M Sell
243,611
-4,020
-2% -$317K 0.3% 66
2014
Q2
$18.7M Buy
247,631
+7,927
+3% +$599K 0.29% 72
2014
Q1
$17.9M Buy
239,704
+698
+0.3% +$49.3K 0.3% 68
2013
Q4
$17.1M Sell
239,006
-108,111
-31% -$6.95M 0.29% 65
2013
Q3
$19.7M Buy
347,117
+3,800
+1% +$226K 0.36% 54
2013
Q2
$19.6M Buy
+343,317
New +$19.9M 0.37% 51

Other funds holding CVS

Shell Asset Management's CVS Position: Q3 2025 in Review

Shell Asset Management reduced its CVS Health (CVS) stake by 78% in Q3 2025, selling an estimated $3.32M and leaving 13,329 shares worth $1M. The position accounts for 0.1% of the portfolio, ranked #232.

Shell Asset Management first reported a position in CVS in Q2 2013 and has held it in 49 quarters since. The position peaked at $25.6M in Q4 2014. 1,835 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Shell Asset Management held 13,329 shares of CVS Health worth $1M as of Q3 2025.
  • Shell Asset Management sold 48,447 CVS Health shares in Q3 2025, an estimated $3.32M.
  • CVS Health made up 0.1% of Shell Asset Management's portfolio in Q3 2025, its #232 holding.
  • Shell Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 49 quarters since.
  • Shell Asset Management's CVS Health position peaked at $25.6M in Q4 2014.
  • 1,835 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.